Toxicity and Mechanisms of Engineered Nanoparticles in Animals with Established Allergic Asthma

Int J Nanomedicine. 2023 Jun 29:18:3489-3508. doi: 10.2147/IJN.S411804. eCollection 2023.

Abstract

Asthma is a chronic respiratory disease that is highly sensitive to environmental pollutants, including engineered nanoparticles (NPs). Exposure to NPs has become a growing concern for human health, especially for susceptible populations. Toxicological studies have demonstrated strong associations between ubiquitous NPs and allergic asthma. In this review, we analyze articles that focus on adverse health effects induced by NPs in animal models of allergic asthma to highlight their critical role in asthma. We also integrate potential mechanisms that could stimulate and aggravate asthma by NPs. The toxic effects of NPs are influenced by their physicochemical properties, exposure dose, duration, route, as well as the exposure order between NPs and allergens. The toxic mechanisms involve oxidative stress, various inflammasomes, antigen presenting cells, immune cells, and signaling pathways. We suggest that future research should concentrate on establishing standardized models, exploring mechanistic insights at the molecular level, assessing the combined effects of binary exposures, and determining safe exposure levels of NPs. This work provides concrete evidence of the hazards posed by NPs in animals with compromised respiratory health and supports the modifying role of NPs exposure in allergic asthma.

Keywords: adjuvant effect; allergic asthma; engineered nanoparticles; mechanisms; mouse model; toxicity.

Publication types

  • Review

MeSH terms

  • Allergens / toxicity
  • Animals
  • Asthma* / chemically induced
  • Humans
  • Models, Animal
  • Nanoparticles* / toxicity
  • Oxidative Stress

Substances

  • Allergens